Jaspe, Jovaida C.

HRN: 20-53-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/29/2026
07/06/2026
IV
600mg
Q8
DM FOOT, R
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: